Figure 2.
OS of elderly patients treated with venetoclax combined with decitabine or azacitidine. Kaplan-Meier curve showing OS survival of patients in the dose escalation as well as dose expansion phases of the trial.60 OS is divided into the 3 different doses of venetoclax used in this trial. This figure was adapted from DiNardo et al.60